Aspire Private Capital’s AB InBev BUD Stock Holding History

Aspire Private Capital’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-71	Closed	-$3K	–	465
2020 Q2	$3K	Buy	71 +68	+2,267%	+$3.18K	﹤0.01%	250
2020 Q1	$0	Sell	3 -8	-73%	-$522	﹤0.01%	264
2019 Q4	$1K	Buy	+11	New	+$916	﹤0.01%	415

Other funds holding BUD

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCF

BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Aspire Private Capital's BUD Position: Q3 2020 in Review

Aspire Private Capital sold out of AB InBev (BUD) in Q3 2020, closing a stake of 71 shares — an estimated $3K sold.

Aspire Private Capital first reported a position in BUD in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q2 2020. 466 funds tracked by Wall St. Rank hold BUD as of Q3 2020.

Aspire Private Capital reported no remaining AB InBev position as of Q3 2020 after selling out during the quarter.
Aspire Private Capital sold 71 AB InBev shares in Q3 2020, an estimated $3K.
Aspire Private Capital first reported a position in AB InBev in Q4 2019 and held it in 3 quarters.
Aspire Private Capital's AB InBev position peaked at $3K in Q2 2020.
466 funds tracked by Wall St. Rank held AB InBev as of Q3 2020.

Based on Aspire Private Capital's 13F filing for Q3 2020, filed 13 Nov 2020.